meglumine antimoniate has been researched along with Amyloidosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buffet, PA; Bullani, R; de Vallière, S; Gillmore, JD; Greub, G; Joneberg, JE; Mary, C; Rotman, S; Tarr, PE | 1 |
1 other study(ies) available for meglumine antimoniate and Amyloidosis
| Article | Year |
|---|---|
AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
Topics: Amphotericin B; Amyloidosis; Anti-HIV Agents; Antiprotozoal Agents; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2009 |